Nobuhiro Ijichi

565 total citations
18 papers, 442 citations indexed

About

Nobuhiro Ijichi is a scholar working on Genetics, Molecular Biology and Oncology. According to data from OpenAlex, Nobuhiro Ijichi has authored 18 papers receiving a total of 442 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Genetics, 11 papers in Molecular Biology and 6 papers in Oncology. Recurrent topics in Nobuhiro Ijichi's work include Estrogen and related hormone effects (11 papers), FOXO transcription factor regulation (4 papers) and Cancer Cells and Metastasis (4 papers). Nobuhiro Ijichi is often cited by papers focused on Estrogen and related hormone effects (11 papers), FOXO transcription factor regulation (4 papers) and Cancer Cells and Metastasis (4 papers). Nobuhiro Ijichi collaborates with scholars based in Japan and United States. Nobuhiro Ijichi's co-authors include Kazuhiro Ikeda, Satoshi Inoue, Kuniko Horie‐Inoue, Hitoshi Tsuda, Akihiko Osaki, Takashi Shigekawa, Toshiaki Saeki, Yasushi Okazaki, Tomohiko Urano and Satoru Takeda and has published in prestigious journals such as Cancer Research, Oncogene and Biochemical and Biophysical Research Communications.

In The Last Decade

Nobuhiro Ijichi

17 papers receiving 436 citations

Peers

Nobuhiro Ijichi

GENET

PRM

ONCOL

Fabiana Zolea Italy

C. Huysmans Belgium

Preetika Balanathan Canada

Mark Van Camp Belgium

Armina A. Kazi United States

Masakazu Souda Japan

Y Yamaguchi Japan

Hirofumi Akashi Japan

Fatemeh Davoodi United States

Fabiana Zolea Italy

Nobuhiro Ijichi

198 ×0.8

99 ×0.6

GENET

159 ×1.3

74 ×0.9

PRM

63 ×0.8

ONCOL

Citations per year, relative to Nobuhiro Ijichi Nobuhiro Ijichi (= 1×) peers Fabiana Zolea

Countries citing papers authored by Nobuhiro Ijichi

Since Specialization

Citations

This map shows the geographic impact of Nobuhiro Ijichi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nobuhiro Ijichi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nobuhiro Ijichi more than expected).

Fields of papers citing papers by Nobuhiro Ijichi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nobuhiro Ijichi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nobuhiro Ijichi. The network helps show where Nobuhiro Ijichi may publish in the future.

Co-authorship network of co-authors of Nobuhiro Ijichi

This figure shows the co-authorship network connecting the top 25 collaborators of Nobuhiro Ijichi. A scholar is included among the top collaborators of Nobuhiro Ijichi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nobuhiro Ijichi. Nobuhiro Ijichi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Kawakami, Hirotaka, Nobuhiro Ijichi, Eriko Matsuda, et al.. (2024). An optimal promoter regulating cytokine transgene expression is crucial for safe and effective oncolytic virus immunotherapy. Translational research. 273. 32–45. 1 indexed citations

Mitsui, Kaoru, et al.. (2017). A Novel Construction of Lentiviral Vectors for Eliminating Tumorigenic Cells from Pluripotent Stem Cells. Stem Cells. 36(2). 230–239. 7 indexed citations

Ijichi, Nobuhiro, Kazuhiro Ikeda, Kuniko Horie‐Inoue, & Satoshi Inoue. (2013). FOXP1 and Estrogen Signaling in Breast Cancer. Vitamins and hormones. 93. 203–212. 22 indexed citations

Ijichi, Nobuhiro, Takashi Shigekawa, Kazuhiro Ikeda, et al.. (2013). Association of Positive EBAG9 Immunoreactivity With Unfavorable Prognosis in Breast Cancer Patients Treated With Tamoxifen. Clinical Breast Cancer. 13(6). 465–470. 6 indexed citations

Ijichi, Nobuhiro, Kazuhiro Ikeda, Hidekazu Kayano, et al.. (2012). Forkhead box transcription factor, forkhead box A1, shows negative association with lymph node status in endometrial cancer, and represses cell proliferation and migration of endometrial cancer cells. Cancer Science. 103(4). 806–812. 24 indexed citations

Ijichi, Nobuhiro, Takashi Shigekawa, Kazuhiro Ikeda, et al.. (2012). Association of Double-Positive FOXA1 and FOXP1 Immunoreactivities with Favorable Prognosis of Tamoxifen-Treated Breast Cancer Patients. Hormones and Cancer. 3(4). 147–159. 31 indexed citations

Shigekawa, Takashi, Nobuhiro Ijichi, Katsumi Ikeda, et al.. (2012). Abstract P6-04-27: EBAG9 immunoreactivity is a potential prognostic factor for poor outcome of breast cancer patients with adjuvant tamoxifen therapy. Cancer Research. 72(24_Supplement). P6–4. 1 indexed citations

Shigekawa, Takashi, Nobuhiro Ijichi, Kazuhiro Ikeda, et al.. (2011). FOXP1, an Estrogen-Inducible Transcription Factor, Modulates Cell Proliferation in Breast Cancer Cells and 5-Year Recurrence-Free Survival of Patients with Tamoxifen-Treated Breast Cancer. Hormones and Cancer. 2(5). 286–297. 47 indexed citations

Ijichi, Nobuhiro, Takashi Shigekawa, Kazuhiro Ikeda, et al.. (2010). Estrogen-related receptor γ modulates cell proliferation and estrogen signaling in breast cancer. The Journal of Steroid Biochemistry and Molecular Biology. 123(1-2). 1–7. 56 indexed citations

10.

Ijichi, Nobuhiro, Kazuhiro Ikeda, Masayo Fujita, et al.. (2009). EPAS1, a Dexamethasone-Inducible Gene in Osteoblasts, Inhibits Osteoblastic Differentiation. 1(1). 28–37. 3 indexed citations

11.

Fujimura, Tetsuya, Satoru Takahashi, Tomohiko Urano, et al.. (2009). Differential expression of estrogen‐related receptors β and γ (ERRβ and ERRγ) and their clinical significance in human prostate cancer. Cancer Science. 101(3). 646–651. 37 indexed citations

12.

Shigekawa, Takashi, Nobuhiro Ijichi, Shin Takayama, et al.. (2009). FOXP1 as a Potential ER Coregulator in Human Breast Cancer.. Cancer Research. 69(24_Supplement). 4149–4149. 1 indexed citations

13.

Ijichi, Nobuhiro, et al.. (2008). Modulation of adipogenesis-related gene expression by estrogen-related receptor γ during adipocytic differentiation. Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms. 1789(2). 71–77. 48 indexed citations

14.

Ijichi, Nobuhiro, Kazuhiro Ikeda, Kuniko Horie‐Inoue, et al.. (2007). Estrogen-related receptor α modulates the expression of adipogenesis-related genes during adipocyte differentiation. Biochemical and Biophysical Research Communications. 358(3). 813–818. 63 indexed citations

15.

Takayama, Ken‐ichi, Kiyofumi Kaneshiro, Shogo Tsutsumi, et al.. (2007). Identification of novel androgen response genes in prostate cancer cells by coupling chromatin immunoprecipitation and genomic microarray analysis. Oncogene. 26(30). 4453–4463. 86 indexed citations

16.

Ijichi, Nobuhiro. (2004). Distal Sox Binding Elements of the B-Crystallin Gene Show Lens Enhancer Activity in Transgenic Mouse Embryos. The Journal of Biochemistry. 135(3). 413–420. 7 indexed citations

17.

Ijichi, Shinji, Nobuhiro Ijichi, & M Osame. (1997). [HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP)].. PubMed. 55(4). 926–33. 2 indexed citations

18.

Ijichi, Shinji, et al.. (1990). [Efficacy of leukocytapheresis and low-dose prednisolone treatment in a patient with HTLV-I-associated myelopathy (HAM)].. PubMed. 30(5). 544–7.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact